Min Li

6.9k total citations · 2 hit papers
142 papers, 4.4k citations indexed

About

Min Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Min Li has authored 142 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Pulmonary and Respiratory Medicine, 54 papers in Molecular Biology and 34 papers in Oncology. Recurrent topics in Min Li's work include Cystic Fibrosis Research Advances (19 papers), Pulmonary Hypertension Research and Treatments (19 papers) and Neonatal Respiratory Health Research (13 papers). Min Li is often cited by papers focused on Cystic Fibrosis Research Advances (19 papers), Pulmonary Hypertension Research and Treatments (19 papers) and Neonatal Respiratory Health Research (13 papers). Min Li collaborates with scholars based in China, United States and Japan. Min Li's co-authors include Tzyh‐Chang Hwang, Yufei Xiang, Xuan Guan, Bingwen Liu, Zhiguang Zhou, William B. Guggino, Kurt R. Stenmark, Shusheng Wang, Ronald W. Raab and Peter J. Schatz and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Min Li

130 papers receiving 4.4k citations

Hit Papers

Can we use interleukin-6 (IL-6) blockade for coronavirus ... 2020 2026 2022 2024 2020 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
    2020 560 citations Min Li et al. profile →
  2. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
    2022 323 citations Min Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Li China 34 2.4k 2.0k 753 563 481 142 4.4k
Christine Kim Garcia United States 33 3.0k 1.2× 1.5k 0.8× 429 0.6× 457 0.8× 1.6k 3.4× 70 6.6k
Tomonobu Koizumi Japan 38 1.9k 0.8× 1.2k 0.6× 881 1.2× 201 0.4× 654 1.4× 303 5.1k
Xianglin Yuan China 36 1.1k 0.5× 2.3k 1.2× 1.2k 1.6× 1.0k 1.8× 535 1.1× 233 5.0k
Daniel Sedding Germany 36 695 0.3× 1.9k 1.0× 455 0.6× 702 1.2× 771 1.6× 137 4.8k
Lin Li China 34 2.7k 1.1× 2.1k 1.1× 2.3k 3.1× 1.1k 2.0× 503 1.0× 210 5.9k
Daniela Terracciano Italy 37 1.2k 0.5× 1.1k 0.5× 451 0.6× 728 1.3× 381 0.8× 134 3.1k
Benjamin D. Medoff United States 38 1.3k 0.5× 1.0k 0.5× 699 0.9× 295 0.5× 597 1.2× 90 4.9k
Hyung J. Chun United States 32 581 0.2× 1.8k 0.9× 456 0.6× 724 1.3× 1.1k 2.2× 65 4.5k
Seiya Kato Japan 30 698 0.3× 993 0.5× 378 0.5× 208 0.4× 462 1.0× 116 3.0k
Jun Yin China 33 810 0.3× 1.3k 0.7× 306 0.4× 464 0.8× 672 1.4× 205 3.5k

Countries citing papers authored by Min Li

Since Specialization
Citations

This map shows the geographic impact of Min Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Li more than expected).

Fields of papers citing papers by Min Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Li. The network helps show where Min Li may publish in the future.

Co-authorship network of co-authors of Min Li

This figure shows the co-authorship network connecting the top 25 collaborators of Min Li. A scholar is included among the top collaborators of Min Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Li. Min Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bu, Fanqin, Guangyu Ding, Lin Yang, et al.. (2025). Lectin-affinity glycosylation pattern analysis of plasma extracellular vesicles: An all-in-one clinical assessment for gastric cancer diagnosis and treatment. Cancer Letters. 631. 217929–217929. 1 indexed citations
2.
Jia, Jian, Min Li, Tian Tian, et al.. (2025). Use of ritlecitinib in patients with alopecia areata refractory to tofacitinib or baricitinib: A single-center retrospective cohort study. Journal of the American Academy of Dermatology. 94(1). 351–353.
3.
4.
Plecitá‐Hlavatá, Lydie, Andrea Brázdová, Cheng‐Jun Hu, et al.. (2023). Microenvironmental regulation of T-cells in pulmonary hypertension. Frontiers in Immunology. 14. 1223122–1223122. 12 indexed citations
5.
Han, Rui, Min Tang, Min Li, et al.. (2023). High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma. Journal of Cancer. 14(17). 3321–3334. 2 indexed citations
6.
Li, Min, et al.. (2023). Classification of benign and malignant parotid tumors based on CT images combined with stack generalization model. Medical & Biological Engineering & Computing. 61(11). 3123–3135. 1 indexed citations
7.
8.
Li, Yongping, et al.. (2023). Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor. European Journal of Pharmacology. 945. 175571–175571. 7 indexed citations
9.
Wang, Zhenwei, Min Li, Jingjie Li, & Naifeng Liu. (2022). Association of lipoprotein(a) with all-cause and cause-specific mortality: A prospective cohort study. European Journal of Internal Medicine. 106. 63–70. 13 indexed citations
10.
Zhao, Zhenyu, Yuhao Zhang, Weijun Liang, et al.. (2022). Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma. Frontiers in Immunology. 13. 1043512–1043512. 4 indexed citations
11.
Cunningham, Christine M., Min Li, Grégoire Ruffenach, et al.. (2022). Y-Chromosome Gene, Uty , Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines. American Journal of Respiratory and Critical Care Medicine. 206(2). 186–196. 45 indexed citations
12.
Ding, Hongmei, Meng Zhao, Jiahui Lei, et al.. (2021). Correlation of amniotic fluid index and placental aquaporin 1 levels in terms of preeclampsia. Placenta. 117. 169–178. 5 indexed citations
13.
Li, Min, et al.. (2020). Prevalence of Intracranial Artery Stenosis in Patients with Acute Ischemic Stroke in a Tertiary Care Hospital of China. SHILAP Revista de lepidopterología. 58(229). 634–639. 1 indexed citations
14.
15.
Hu, Chengping, et al.. (2019). The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients. Cancer Medicine. 9(1). 84–93. 31 indexed citations
16.
Li, Min, Chunmei Zhang, & Rong Geng. (2019). Dendritic fibromyxolipoma: a clinicopathologic analysis of five cases and review of literature. 31(7). 489–491.
17.
Frid, Maria G., B.A. McKeon, Joshua M. Thurman, et al.. (2019). Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 201(2). 224–239. 81 indexed citations
18.
Gao, Jianjun, et al.. (2017). L-Carnitine Ameliorates the Decrease of Aquaporin 2 Levels in Rats with Cisplatin-Induced Kidney Injury. ˜The œNephron journals/Nephron journals. 135(4). 315–325. 7 indexed citations
19.
20.
Frid, Maria G., Min Li, Danielle Burke, et al.. (2009). Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(6). L1059–L1072. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Kim Garcia Breakdown of academic impact, for papers by Tomonobu Koizumi Breakdown of academic impact, for papers by Xianglin Yuan Breakdown of academic impact, for papers by Daniel Sedding Breakdown of academic impact, for papers by Lin Li Breakdown of academic impact, for papers by Daniela Terracciano Breakdown of academic impact, for papers by Benjamin D. Medoff Breakdown of academic impact, for papers by Hyung J. Chun Breakdown of academic impact, for papers by Seiya Kato Breakdown of academic impact, for papers by Jun Yin
Rankless by CCL
2026